DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Mitochondrial cholesterol and cancer
Cholesterol is a crucial component of membrane bilayers that determines their physical and functional properties.
Cells largely satisfy their need for cholesterol through the novo synthesis from acetyl-CoA and this demand
is particularly critical for cancer cells to sustain dysregulated cell proliferation. However, the association between
serum or tissue cholesterol levels and cancer development is not well established as epidemiologic data do not
consistently support this link. While most preclinical studies focused on the role of total celular cholesterol, the
specific contribution of the mitochondrial cholesterol pool to alterations in cancer cell biology has been less
explored. Although low compared to other bilayers, the mitochondrial cholesterol content plays an important
physiological function in the synthesis of steroid hormones in steroidogenic tissues or bile acids in the liver and
controls mitochondrial function. In addition, mitochondrial cholesterol metabolism generates oxysterols, which
in turn, regulate multiple pathways, including cholesterol and lipid metabolism as well as cell proliferation. In
the present review, we summarize the regulation of mitochondrial cholesterol, including its role in mitochondrial
routine performance, cell death and chemotherapy resistance, highlighting its potential contribution to cancer.
Of particular relevance is hepatocellular carcinoma, whose incidence in Western countries had tripled in the past
decades due to the obesity and type II diabetes epidemic. A better understanding of the role of mitochondrial
cholesterol in cancer development may open up novel opportunities for cancer therapy., We acknowledge the support from grants PID2019-111669RB,
SAF2017-85877R and SAF2015-73579-JIN from Plan Nacional de I + D
funded by the Agencia Estatal de Investigacion ´ (AEI) and the Fondo
Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; the
center grant P50AA011999 Southern California Research Center for
ALPD and Cirrhosis funded by NIAAA/NIH; as well as support from
AGAUR of the Generalitat de Catalunya SGR-2017-1112, European
Cooperation in Science & Technology (COST) ACTION CA17112 Prospective European Drug-Induced Liver Injury Network, the “ER stressmitochondrial cholesterol axis in obesity-associated insulin resistance
and comorbidities”-Ayudas FUNDACION BBVA, the Red Nacional 2018-
102799-T de Enfermedades Metabolicas ´ y Cancer ´ and the Project
201916/31 Contribution of mitochondrial oxysterol and bile acid
metabolism to liver carcinogenesis 2019 by Fundacio ´ Marato TV3.
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-111669RB
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 SAF2017-85877R
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 SAF2015-73579-JIN